Showing results 20 to 34 of 34
< previous
| Issue Date | Title | Author(s) |
| 2021-02 | Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study. | Daniels, B; Luckett, T; Holliday, S; Liauw, W; Lovell, M; Phillips, J; Rowett, D; John, TN; Tervonen, H; Pearson, S-A |
| 2020-01-03 | Pharmacovigilance in Hospice/Palliative Care: De-Prescribing Combination Controlled Release Oxycodone-Naloxone | Clark, K; Byrne, PG; Hunt, J; Brown, L; Rowett, D; Watts, G; Lovell, M; Currow, DC |
| 2022-04-10 | Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. | Hussein, A; Digges, M; Chang, S; Hunt, J; Doogue, M; Rowett, D; Agar, M; Sinnarajah, A; Kain, D; Allan, S; Boland, JW; Currow, DC |
| 2015-01-01 | Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
| 2013-11-01 | Pharmacovigilance in hospice/palliative care: Net effect of haloperidol for delirium | Crawford, GB; Meera Agar, M; Quinn, SJ; Phillips, J; Litster, C; Michael, N; Doogue, M; Rowett, D; Currow, DC |
| 2016-09-01 | Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
| 2012-10-01 | Pharmacovigilance in hospice/palliative care: Rapid report of net clinical effect of metoclopramide | Currow, DC; Vella-Brincat, J; Fazekas, B; Clark, K; Doogue, M; Rowett, D |
| 2014-02-01 | Prescribing for comorbid disease in a palliative population: Focus on the use of lipid-lowering medications | Russell, BJ; Rowett, D; Abernethy, AP; Currow, DC |
| 2014-01-01 | Pro re nata prescribing in a population receiving palliative care: A prospective consecutive case note review | Russell, BJ; Rowett, D; Currow, DC |
| 2017-10-01 | The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care | To, THM; LeBlanc, TW; Eastman, P; Neoh, K; Agar, MR; To, LB; Rowett, D; Vandersman, Z; Currow, DC |
| 2016-01-01 | Quantifying the burden of opioid medication errors in adult oncology and palliative care settings: A systematic review | Heneka, N; Shaw, T; Rowett, D; Phillips, JL |
| 2012-10-10 | Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain | Hardy, J; Quinn, S; Fazekas, B; Plummer, J; Eckermann, S; Agar, M; Spruyt, O; Rowett, D; Currow, DC |
| 2020-02-17 | Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners. | Luckett, T; Newton-John, T; Phillips, J; Holliday, S; Giannitrapani, K; Powell-Davies, G; Lovell, M; Liauw, W; Rowett, D; Pearson, S-A; Raymond, B; Heneka, N; Lorenz, K |
| 2020-09 | Symptomatic Events in a Community Palliative Care Population: A Prospective Pilot Study. | To, THM; Collier, A; Agar, MR; Rowett, D; Currow, DC |
| 2013-03-01 | Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation | Clark, K; Rowett, D; Robinson, M; Currow, DC |
